IBA chooses 3DEXPERIENCE platform from Dassault Systèmes to support the development of - cancer treatment solutions
Dassault Systèmes (Euronext Paris: # 13065, DSY.PA) the 3DEXPERIENCE Company, world leader in 3D design software, 3D digital mock Up Up and Product Lifecycle Management (PLM) solutions, today announced that Ion Beam Applications SA (IBA), the first medical device and a pioneer manufacturer in proton beam therapy for cancer treatment, selected the 3DEXPERIENCE platform based on V6 architecture and its "Licensed to Cure for medical devices" industry solution experience. With "Licensed to Cure for Medical Devices", IBA will support its medical accelerator solutions development process.
The changing medical needs of a growing world population and advances in medical research, extreme medical challenges up device manufacturers to accelerate the development of innovative equipment and safe, which comply stringent national and international regulations. IBA wanted to make the transition from engineering-to-order a labor approach to a standardized collaborative development approach which results in a long series of machines ready for production which correspond to a variety of customer requests complex.
Thanks to "Licensed to Cure for medical devices," global teams IBA get centralized access to the most current design information, regulatory and quality information, ensuring regulatory compliance. Users spend some time looking for product data when they need to meet the request of a regulatory body for information. IBA complete traceability and can well protect its intellectual property from the company. This helps to maintain its competitive advantage over other medical device companies.
"With" Licensed to Cure for Medical Devices "we have a unique unifying development in which we can leverage all our data, processes and methodologies for future reuse, and hence improve productivity of all downstream processes. "said Thomas Canon, PLM program manager at IBA
" medical device manufacturers have a dual responsibility :. patients with innovative therapeutic solutions and regulatory bodies must ensure that their equipment meets the stringent safety and quality protocols, "said Monica Menghini, Executive Vice President, corporate Strategy, industry and marketing, Dassault Systèmes." the integrated "Licensed to Cure for Medical Device 'industry solution experience gives the life sciences industry a competitive way to provide a faster meet the needs of operators and, ultimately, faster access to treatment for patients. "
EmoticonEmoticon